Marjo Taal & Hanna Bos 26 juli 2018 - Soa Aids Nederland
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Syndemics….. synergie! https://www.rivm.nl/en/Topics/S/Sexually_transmitted_infecti ons_STIs/Video/Video_STI_s.std?ext=.mp4
HIV and STI Synergy Inflammation and/or ulceration BEHAVIOR Condomless sex ↑HIV STI PrEP and Multiple partners transmission TasP and/or acquisition Higher risk partners, ↑ risk of HIV-infected partner
HIV and STI Synergy Inflammation and/or ulceration ↑HIV BEHAVIOR Condomless sex transmission STI PrEP and Multiple partners and/or acquisition TasP Higher risk partners, ↑ risk of HIV-infected partner
• it‘s the mucosa/microbioom! • DGI: gedissimineerde gonorroe go vaccin & China • MSM migrants: prioriteit PrEP • HCV eliminatie: gedragsverandering!
Syfilis
Congenital Syphilis Cases by Year of Birth and rates of Primary and Secondary Syphilis among Women, United States, 2007–2016 Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
Decline in the number of penicillin API manufacturers over the past decade, 1995-2018 Pre-1995 1995-2000 1995- 2001-2005 2001- 2006-2010 2006- 2011-2015 2011- 2016 Pre-1995 Current 2000 2005 2010 2015 • CSPC China • NCPC China • Jiangxi Dongfeng China • Sandoz Germany Closed plant Acquired by • Wyeth India Pfizer Acquired by • King USA Pfizer Ended • Pfizer USA production Ended • Alembic India production Ended • Bristol Europe UK production Ended • Aventis France production Acquired by • GIST Brocades Netherlands DSM* Source: Melanie Taylor, RHR/STI, WHO Geneva.
A Vicious Cycle: STDs predict future HIV Risk Rectal GC or CT 1 in 15 MSM were diagnosed with HIV within 1 year.* Primary or Secondary Syphilis 1 in 18 MSM were diagnosed with HIV within 1 year.** No rectal STD or syphilis infection 1 in 53 MSM were diagnosed with HIV within 1 year.* *STD Clinic Patients, New York City. Pathela, CID 2013:57; **Matched STD/HIV Surveillance Data, New York City. Pathela, CID 2015:61
Syfilis Toepassing in jouw werk? Vragen aan experts? Vragen aan andere disciplines?
PrEP en soa
Risk Compensation adjustment of behaviour in response to a perceived reduction in risk. •Critical issue in the public health implementation of biomedical interventions: Could increased risky sexual behavior counteract the biological efficacy against HIV? •Behavioral adaptation: Behavioral changes triggered by a safety measure: reduction in condom use •Behavioral disinhibition: Lack of restraint with more risk taking behaviors: increasing nr of partners, nr of sexual acts, chemsex… •STIs: Best objective measure of risk compensation and most feared consequence of risk compensation •Individual vs. population impact of biomedical interventions: risk compensation among people not using PrEP/TASP •Risk management plan: Assess the public health impact of PrEP Cassell BMJ 2006
Figure 10 New diagnoses of HIV and STIs from 1996 to 2015 in MSM in England Unemo M et al. Lancet Infect Dis 2017
Unemo M et al. Lancet Infect Dis 2017
Community-Level Changes in11Condom use with Figure Casual Partners Among MSM 30% 1% 46% The Lancet Infectious Diseases 2017 17, e235-e279DOI: (10.1016/S1473-3099(17)30310-9) Copyright Holt M. et al . Lancet HIV 2018
Meta-analyis of effect of PrEP on STIs diagnosis among MSM Significant increase in any rectal STI diagnosis (OR: 1.39, 95% CI: 1.03-1.87) Significant increase in rectal chlamydia (OR: 1.59, 95% CI: 1.19-2.13) Increase in STIs rates in more recent studies (OR: 1.47, 95% CI: 1.05-2.05) Traeger MW et al. CID 2018
Partners, not condom use drive STIs rates • SPARK: Community-based PrEP demonstration project in NYC • 261 MSM followed until M12 after PrEP intitiation • Decrease in condom use: 61% to 46% Predicting Factors of STIs aOR 95% CI p Age < 25 years old 3.67 1.11-12.25 < 0.05 > 5 casual partners at BL 2.80 1.43-5.50 < 0.01 STIs in 6 months pre-PrEP 2.22 1.07-4.59
PrEP en soa Toepassing in jouw werk? Vragen aan experts? Vragen aan andere disciplines?
STI clinic in the future Dean Street Express, London
Time to treatment Pre Express Post Express Time attendance to informed of result (hours) 183 3.8 Time attendance to treatment 238 48 (hours) Byrne et al, BASHH oral presentation 2015 Whitlock et al, Int J STD&AIDS 2018
CT/GC in HIV negative MSM 15.000 Chlamydia any site 1.000 Diagnoses 800 Tests 10.000 600 400 5.000 200 - - 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 2012 Chlamydia 2013 diagnoses 2014 Chlamydia 2015 tests 2016 2017 Gonorrhoea any site 15.000 2.000 Diagnoses 1.500 Tests 10.000 1.000 5.000 500 - - 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 2012 Gonorrhoea 2013 diagnoses 2014 Gonorrhoea2016 2015 tests 2017 HIV and STI test and diagnosis trends in MSM attending Dean Street Clinic, 2012 to 2016 (GUMCAD)
STI models of care Private Public Pro’s Pro’s • High coverage • Serve high-risk populations • Can easily provide basic STI screening • Diagnose and treat large numbers of services STIs Contra’s • High level of expertise • Most patients not at high risk Contra’s • STIs not a priority • Low coverage • Lack of expertise • Stigma Public Health Impact Public Health Impact • Generalized epidemics • Concentrated epidemics
Concentrated Epidemics Most of these infections are HIV overlapping epidemics among populations that STD clinics have Syphilis access to: Gonorrhea • • MSM Sex workers LGV • • injection drug users other high-risk populations Hepatitis C
Online services: SH24 Mobile friendly and online
Digital vending machine BioSURE HIV self-tests: 3rd generation Wall mounted at eye level Touch screen Robust - liquid proof – secure (>300 machines, no incidents) Lifespan ‘hundreds of thousands’ of vends Little maintenance, can be done remotely Access website for live monitoring of sales, issues and epidemiological data Installed Brighton Sauna June 2017
GPS to predict the next event You probably met gonorroea at ….. Your nearest STI care that is open now is…….
STI clinic in the future ∞ Social media campaigns Branded services tailored to diverse Tailored risk reduction needs advice online Outreach in hot spots Links to community and/or to support organisations local community needs Wellbeing programme Self-sampling Self-testing
Barriers Funding constraints • a small pot for prevention • complacency amongst policy-makers/funders/… Provider constraints slow to adopt new technologies, resistant to change, paternalistic not knowing/connecting with users negative attitudes persist Population constraints fear and stigma have not gone away
Solutions Funding constraints • tackle the cost of tests – a global issue • make throughput efficient for lab (upscale) and clinic (differentiate) Provider constraints top-down, bottom-up – create the team that gets the technology keep it lively – refresh campaigns, start new ones, reward staff, trust the users Population constraints work with community champions on positive messages – be inclusive, celebrate diversity
STI clinic in the future Toepassing in jouw werk? Vragen aan experts? Vragen aan andere disciplines?
You can also read